KL
Kalaris Therapeutics Inc (KLRS)
NASDAQ·Healthcare·Biotechnology
$1.86
+3.33%
Mkt Cap $65.65M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$18.00
Range $14.00 – $23.00
Implied Upside
+867.7%
Consensus $18.00 vs current $1.86
NASDAQ·Healthcare·Biotechnology
$1.86
+3.33%
Mkt Cap $65.65M
No recent rating data.
Price Target (5 analysts)
$18.00
Range $14.00 – $23.00
+867.7%
Consensus $18.00 vs current $1.86